Alzheimer's Disease (AD) has devastating consequences for patients during its slow, progressive 28 course. It is important to understand the pathology of AD onset. Recently, circular RNAs 29 (circRNAs) have been found to participate in many human diseases including cancers and 30 neurodegenerative conditions. In this study, we mined the published dataset on the AMP-AD 31 Knowledge Portal from the Mount Sinai Brain Bank (MSBB) to describe the circRNA profiles at 32 different AD stage in brain samples from four AD patients brain regions, anterior prefrontal cortex, 33 superior temporal lobe, parahippocampal gyrus, and inferior frontal gyrus. We found in total 147 34 circRNAs to be differentially expressed (DE) during AD progression in the four regions. We also 35 characterized the mRNA-circRNA co-expression network and annotated the potential function of 36 circRNAs based on the co-expressed modules. Based on our results, we propose that 37 parahippocampal gyrus is the most circRNA-regulated region during the AD progression. The 38 strongest negatively AD stage-correlated module in parahippocampal gyrus were enriched in 39 cognitive disability and pathological-associated pathways such as synapse organization and 40 regulation of membrane potential. Finally, the regression model based on the expression pattern of 41 DE circRNAs in the module could help to distinguish the disease severity of patients, further 42 supported the importance of circRNAs in AD pathology. In conclusion, our finding indicates that 43 circRNAs in parahippocampal gyrus are possible regulators of AD progression and potentially be a 44 therapeutic target or of AD. 45 46 47 48 3
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116
We then performed differential expression analysis to observe the relationship between circRNA expression 117 and AD progression. We found that the majority of circRNA decreased with increased CDR stage in all four 118 brain regions, irrespective of circRNA expression level and differential enrichment ( Supplementary Table 1 ).
119
A total of 147 circRNAs was significantly DE when the CDR went from zero (no dementia) to five (terminal 120 stage of dementia) at FDR <= 0.05 in all four brain regions (Fig. 2) , but the distribution of the 147 circRNAs 121 was highly specific. Only four of the 147 differentially expressed circRNAs (2.7%) are shared across the 122 four brain regions, and the number of region-specific differentially expressed circRNAs are 19 (12.9%), 9 123 (6.12%), 54 (23.8%) and 35 (36.7%) in aPFC, STL, PHG, and IFG, respectively ( Supplementary Fig. 2 ). In 124 each brain region, 35,21,77 and 61 circRNAs were differentially expressed. Among these significantly 125 differentially expressed circRNAs, 12,7,33,21 were up-regulated, and 23,14,44,40 circRNAs were 126 downregulated with the progression of dementia in aPFC, STL, PHG, and IFG, respectively. Although the profiling data showed that IFG had the highest circRNA expression, PHG was the region with the most 128 significantly changed circRNAs during the AD progression. 129 130 circRNA-mRNA co-expression network analysis and functional annotation 131 Given the global deregulation in circRNA expression during AD progression we speculated that a correlated 132 dysregulation of circRNAs and mRNAs during cognitive decline could suggest a functional role in shared 133 pathways. We therefore constructed a circRNA-mRNA co-expression network to capture the relationship 134 between circRNAs and mRNAs. Moreover, the co-expression network aided in the functional enrichment 135 test for circRNAs. Despite numerous reports suggesting the function of circRNAs, the experimentally 136 validated functional annotation of most circRNAs is still far from completion. Therefore, considering that the 137 mRNAs and circRNAs in the same module could be involved in similar mechanisms during disease 138 progression, we assumed that the mRNAs in a module could be used to estimate circRNA function. Supplementary Table 2~5 ). All modules in aPFC and STL were weakly associated with CDR, consistent 146 with a previous study showing that these two regions were the least important of the four brain regions in 147 dementia (Wang et al., 2016) . Surprisingly, although IFG was shown to be an important region for AD in the 148 previous study, and it was the region with the highest circRNA expression in our study, the association 149 between the IFG transcriptome and the CDR score was nearly as weak as for aPFC and STL. The maximum 150 absolute correlation coefficients of the three regions were 0.32, compared to 0.51 for the PHG. This, 151 however, agreed with the observation that PHG had more significantly DE circRNAs than all the other 3 152 regions, suggesting that circRNAs in PHG were most associated with AD progression. We therefore focused 153 on the functional role of circRNAs in this specific region. In PHG, the module with highest correlation 7 coefficient was 'violet' (r = 0.49 and P value = 8^10-10) and the lowest was 'brown' (r = -0.51 and P value 155 = 2^10-10).
157
For each module, the host genes of mRNAs and circRNAs that significantly changed with the CDR were 158 then extracted for GO and DO analysis. The brown module was enriched in important AD pathological 159 mechanisms such as membrane potential regulation and synaptic function, and advanced cognitive functions 160 including behavior, learning or memory and cognition(Supplementary Figure 4A) . The DO enrichment test 161 also showed that the brown module was significantly related to mental disorders such as attention deficit 162 hyperactivity disorder, autism, depression, and epilepsy (Supplementary Figure 4B Given that circRNAs in the PHG brown module are related to disease progression, we selected 13 circRNAs 175 in the PHG brown module (see methods for specific criteria) as promising candidates involved in the 176 pathological process. We grouped individuals into 3 CDR groups by severity and plotted the expression 177 differences for the 13 circRNAs in Supplementary Figure 5 . We then used a multinomial regression model to 178 quantify how well the 13 circRNAs predicted any of the three AD severity groups (model and analysis 179 details are described in the methods section). The result is shown in Supplementary figure 6. To further 180 examine the association between circRNAs and AD progression, we selected a subset of five circRNAs that each had an area under the ROC curve (AUC) >= 0.7 in Supplementary Figure 6 and found their joint 182 predictive value for AD to be significant (p = 0.035). The ROC curve for this model is shown in Fig 
197
Comparing all four regions studied, we found that although IFG was the region with the most enriched 198 circRNA expression, PHG was the region in which circRNAs were most related to the cognitive decline in 199 AD, and the circRNAs in PHG were enriched in AD pathological pathway. Considering that PHG is mainly 200 responsible for advanced cognitive abilities (e.g, associative learning), and that many reports have indicated 201 that PHG atrophy could be an early symptom of AD patients (Echávarri et al., 2011; Krumm et al., 2016) , the 202 abnormal change of circRNAs implies a functional association of circRNAs in PHG and AD progression.
203
We also built a regression model to test the association between circRNAs and AD. Due to the limited 204 number of available independent datasets, we used 70% of the samples in our dataset for model training and 205 30% for the performance test, while all samples were used for DE and co-expression network analysis. The 206 test data for the regression model was therefore not fully independent, and further validation is necessary to 207 confirm the results. Nevertheless, the regression model showed that the selected circRNAs in PHG improved the classification of patients at different AD stages. Our results support that the selected circRNAs might be 209 involved in the AD progressive pathology and could be shortlisted candidates for experimental analyses.
211
Finally, considering the high stability of circRNAs and that circRNAs have been found to circulate in the 212 bloodstream encapsulated in exosomes (Xu, Guo, Li, & Yu, 2015) , it is possible that circRNA could be used 213 for future diagnostic approaches for AD based on blood samples. Although it is necessary to further confirm 214 the robustness of the circRNA candidates described here and determine if they can be detected in exosomes 215 or biofluids, our research describes the AD-associated circRNA changes and pointed out the potential 216 importance of PHG circRNAs during the AD disease process. The results could also provide biological 217 insights to narrow down candidates for further studying circRNAs and potential AD therapeutic targets. Supplementary Table 6 .
To quantify circRNA expression in the AD brain regions, the BAM files and the unmatched FastQ files 236 (containing reads that failed to map to the reference genome) of the same individual were downloaded, 237 converted and merged back to the FastQ file containing all sequenced reads with Picard(v2.7.1)("Picard 238 Tools -By Broad Institute," n.d.) and then re-mapped to the human reference genome hg19 with the Supplementary Fig 7) ; the network construction then followed the tutorial provided by the WGCNA 
282
Given the sparsity of functional information for circRNAs, the mRNAs that were significantly changed 283 during cognitive decline (FDR <= 0.05) and in the most positively-or negatively CDR-correlated co-284 expression modules were also included in the functional enrichment test, while all highly expressed mRNAs 285 and circRNAs were used as the background for the test. The redundant enriched ontology terms were 286 trimmed by the clusterProfiler, and the remaining terms with P value <0.05 were selected.
We found 13 circRNAs that passed both the following criteria: (1) significantly DE during cognitive decline 290 (FDR <= 0.05 and log2 fold change >= 0.2). (2) member of the most trait-related WGCNA co-expression 291 modules. These 13 circRNAs were analyzed further in a multinomial regression model. All individuals were 292 categorized as three disease stages: healthy (CDR less than one), mild cognitive impairment (MCI, CDR 293 between one and three) and AD (CDR higher than three), which was then used as the outcome in the model.
294
We included the following covariates in the base model: age of death (AOD), sex, batch and the first 3 295 principal components of circRNA expression. We then examined the relative area under the receiver 
301
The number of samples in each group in training and testing datasets for the regression model are listed in 302 Supplementary Table 9 . The five most strongly associated circRNAs among the 13 examined individually in 303 the regression were subsequently selected for further analysis. Using the same base model, we included the 304 five circRNAs as covariates and examined the relative AUC. 
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